TITO R MENDOZA to Dacarbazine
This is a "connection" page, showing publications TITO R MENDOZA has written about Dacarbazine.
Connection Strength
0.183
-
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol. 2013 Nov 10; 31(32):4076-84.
Score: 0.099
-
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas. Clin Cancer Res. 2021 06 15; 27(12):3298-3306.
Score: 0.042
-
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma. Neuro Oncol. 2021 03 25; 23(3):468-477.
Score: 0.042